These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36446643)

  • 1. Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer.
    Wang Y; Chen F; Zhou H; Huang L; Ye J; Liu X; Sheng W; Gao W; Yu H; Wang F
    Small Methods; 2023 May; 7(5):e2200888. PubMed ID: 36446643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
    Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
    Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
    Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
    Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Vesicles-Encapsulated RSL-3 Enable Anti-Angiogenesis and Induce Ferroptosis to Inhibit Pancreatic Cancer Progress.
    Zhang Y; Huang Z; Cheng J; Pan H; Lin T; Shen X; Chen W; Chen Q; Gu C; Mao Q; Liang Y
    Front Endocrinol (Lausanne); 2022; 13():865655. PubMed ID: 35399954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ferroptosis in pancreatic cancer: a double-edged sword.
    Chen X; Kang R; Kroemer G; Tang D
    Trends Cancer; 2021 Oct; 7(10):891-901. PubMed ID: 34023326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells.
    Kuang F; Liu J; Xie Y; Tang D; Kang R
    Cell Chem Biol; 2021 Jun; 28(6):765-775.e5. PubMed ID: 33539732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity.
    Zhang H; Zhuo Y; Li D; Zhang L; Gao Q; Yang L; Yuan X
    Eur J Pharmacol; 2022 Jul; 926():175028. PubMed ID: 35569552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy.
    Gao M; Deng J; Liu F; Fan A; Wang Y; Wu H; Ding D; Kong D; Wang Z; Peer D; Zhao Y
    Biomaterials; 2019 Dec; 223():119486. PubMed ID: 31520887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    Hung WC; Lee DY; Chiang EI; Syu JN; Chao CY; Yang MD; Tsai SY; Tang FY
    PLoS One; 2020; 15(11):e0241186. PubMed ID: 33137095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model.
    Ahmad G; Mackenzie GG; Egan J; Amiji MM
    Mol Cancer Ther; 2019 Nov; 18(11):1961-1972. PubMed ID: 31439714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
    Ma Y; Li J; Wang H; Chiu Y; Kingsley CV; Fry D; Delaney SN; Wei SC; Zhang J; Maitra A; Yee C
    Gastroenterology; 2020 Jul; 159(1):306-319.e12. PubMed ID: 32179091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic ferroptosis-gemcitabine chemotherapy of the gemcitabine loaded carbonaceous nanozymes to enhance the treatment and magnetic resonance imaging monitoring of pancreatic cancer.
    Zhang G; Li N; Qi Y; Zhao Q; Zhan J; Yu D
    Acta Biomater; 2022 Apr; 142():284-297. PubMed ID: 35151925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.
    Zhou W; Lim A; Elmadbouh OHM; Edderkaoui M; Osipov A; Mathison AJ; Urrutia R; Liu T; Wang Q; Pandol SJ
    Free Radic Biol Med; 2024 Feb; 212():493-504. PubMed ID: 38184120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.
    Han W; Duan X; Ni K; Li Y; Chan C; Lin W
    Biomaterials; 2022 Jan; 280():121315. PubMed ID: 34920370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
    Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
    Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
    Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma.
    Ma H; Chen X; Mo S; Zhang Y; Mao X; Chen J; Liu Y; Tong WM; Lu Z; Yu S; Chen J
    Cell Death Differ; 2023 Aug; 30(8):1988-2004. PubMed ID: 37479744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.